Edmond Kwan Profile
Edmond Kwan

@EdmondMKwan

Followers
427
Following
1K
Statuses
98

Medical Oncologist and Lab Head at Eastern Health and Monash University | @PCF_Science Young Investigator and @ANZUPtrials Synchrony Fellowship awardee

Melbourne, Australia
Joined March 2018
Don't wanna be here? Send us removal request.
@EdmondMKwan
Edmond Kwan
4 months
RT @ReneaTaylor1: Thrilled that @EdmondMKwan will join @Monash_FMNHS as a Senior Research Fellow after completing his world-class training…
0
2
0
@EdmondMKwan
Edmond Kwan
4 months
@MirNabiel @PCF_Science Congratulations, @MirNabiel 👏 - excited to see you and your team's work evolve in the coming years #gerionc
0
0
3
@EdmondMKwan
Edmond Kwan
4 months
RT @MirNabiel: So thankful for receipt of the PCF Young Investigator Award. @PCF_Science
Tweet media one
0
2
0
@EdmondMKwan
Edmond Kwan
4 months
RT @Prof_IanD: Very much looking forward to having you with us at @EHCSMonash @easternhealthau @MonashBDI @Monash_FMNHS
0
2
0
@EdmondMKwan
Edmond Kwan
8 months
RT @davcmed: Glad to be able to share some first results from our @pros_tic prospective registry. Also very happy to be able to communicate…
0
2
0
@EdmondMKwan
Edmond Kwan
8 months
RT @ANZUPtrials: Great to see @ANZUPtrials #TheraP poster presented by @EdmondMKwan at #ASCO24 with research from @ResearchWyatt. Thanks to…
0
14
0
@EdmondMKwan
Edmond Kwan
8 months
RT @chavarriagaj: #ASCO24 An exploratory analysis of TheraP assessing ctDNA% as a predictor of treatment efficacy of Lu-PSMA-617 vs. Cabazi…
0
4
0
@EdmondMKwan
Edmond Kwan
8 months
RT @DrMHofman: @AttardLab highlighting #TheraP ctDNA biomarkers. The figure speaks for itself. A candidate predictive biomarker. Don't miss…
0
21
0
@EdmondMKwan
Edmond Kwan
9 months
< 1 wk to go! Excited to present correlatives from @ANZUPtrials #TheraP, funded by @PCF_Science Challenge Award to @ResearchWyatt + team. Huge thank you to mentors in #TheraP TMC, investigators + generosity of participants & families. Come say 👋at Board 461 at PCa poster sesh!
@neerajaiims
Neeraj Agarwal, MD, FASCO
9 months
Ab#5055 @ASCO #ASCO24 by @EdmondMKwan👉�In TheraP ph2 trial of Lu-177 vs. cabazitaxel in mCRPC #prostatecancer 👉 Higher ctDNA fraction associated with⬇️PSMA exp, ⬆️ FDG uptake, & ⬇️response to Lu-177👇#AlexanderWyatt @OncoAlert @urotoday @PCF_Science
Tweet media one
Tweet media two
Tweet media three
2
4
24
@EdmondMKwan
Edmond Kwan
1 year
Grateful for @ConquerCancerFd Merit Award recognizing work at @VanProstateCtr @ResearchWyatt and @BCCancer, alongside talented @MurthaAj. Work supported by @PCF_Science. Excited to catch up with friends next wk at 20th ASCO #GU24. Please drop by Board J12 (Abs 204) to say 👋!
@ConquerCancerFd
Conquer Cancer, the ASCO Foundation
1 year
We are excited to announce the 32 recipients of 2024 GU Cancers Symposium Merit Awards. It is an honor to help send these abstract authors to the symposium to share their work. #GU24
Tweet media one
5
5
42
@EdmondMKwan
Edmond Kwan
1 year
RT @ResearchWyatt: Our latest study with @piet_ost, of whole prostates, lymph nodes, and ctDNA at initial diagnosis in de novo metastatic p…
0
67
0